A5059054525- Inflammatory Bowel Disease
- Microscopic Colitis
- Colorectal Cancer Screening and Detection
- Delphi Technique in Research
- Systemic Lupus Erythematosus Research
- Meta-analysis and systematic reviews
- Celiac Disease Research and Management
- Health Systems, Economic Evaluations, Quality of Life
Université Paris Cité
2018-2025
Institut Mondor de Recherche Biomédicale
2024
Inserm
2018
Délégation Paris 5
2018
Hôtel-Dieu de Paris
2018
Assistance Publique – Hôpitaux de Paris
2018
Sorbonne Paris Cité
2018
The Montreal classification has been widely used in Crohn's disease since 2005 to categorize patients by the age of onset (A), location (L), behavior (B), and upper gastrointestinal tract perianal involvement. With evolving management paradigms disease, we aimed assess performance gastroenterologists applying classification. An online survey was conducted among participants at an international educational conference on inflammatory bowel diseases. Participants classified 20 theoretical cases...
Abstract Background Vedolizumab is often used as the first-line advanced therapy for patients with moderate to severe ulcerative colitis (UC). There currently no data reporting efficacy and safety of second-line treatments after initial vedolizumab failure. The objective our study was compare anti-TNF, ustekinumab, tofacitinib 2nd line treatment UC exposure. Methods We conducted a retrospective multicenter in 27 French Belgian centers. All consecutive treated between January 2019 June 2023...